Lucira Health Inc

Lucira Health Inc

LHDX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$18.36M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lucira Health IncLucira Health Inc-0.2--235%0.10.8

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$18.36 Million
Enterprise Value$26.68 Million
Earnings per Share$-1.86
Beta3.76
Outstanding Shares40,216,244

Return

Return on Equity-234.86%ROE
Return on Assets-75.59%
Return on Invested Capital-132.82%

Valuation & Multiples

P/E Ratio-0.24P/E Ratio
PEG-0.07PEG
Price to Sales0.09Price to Sales
Price to Book Ratio0.45Price to Book Ratio
Enterprise Value to Revenue0.13
Enterprise Value to EBIT-0.19
Enterprise Value to Net Income-1
Total Debt to Enterprise1.8
Debt to Equity0.79Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Lucira Health Inc

57 employees

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-...

Lucira Health Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.